Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease

被引:96
|
作者
Caminiti, Silvia Paola [1 ,2 ]
Presotto, Luca [2 ]
Baroncini, Damiano [3 ]
Garibotto, Valentina [4 ]
Moresco, Rosa Maria [5 ,6 ]
Gianolli, Luigi [7 ]
Volonte, Maria Antonietta [3 ]
Antonini, Angelo [8 ,9 ]
Perani, Daniela [1 ,2 ,7 ]
机构
[1] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Div Neurosci, Via Olgettina 58, I-20132 Milan, Italy
[3] Osped San Raffaele, Dept Neurol, Via Olgettina 60, I-20132 Milan, Italy
[4] Univ Geneva, Geneva Univ Hosp, Dept Med Imaging, Geneva, Switzerland
[5] IBFM CNR, Segrate, Italy
[6] Univ Milano Bicocca, Dept Hlth Sci, Tecnomed Fdn, Monza, Italy
[7] Osped San Raffaele, Nucl Med Unit, Via Olgettina 60, I-20132 Milan, Italy
[8] IRCCS Hosp San Camillo, Parkinsons Dis & Movement Disorders Unit, Via Alberoni 70, I-30126 Venice, Italy
[9] Univ Padua, Dept Neurosci DNS, Via Giustiniani 5, I-35128 Padua, Italy
关键词
Parkinson's disease; Positron emission tomography; Dopamine transporter; Axonal damage; Molecular connectivity; VENTRAL TEGMENTAL AREA; POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL CONNECTIVITY; SUBSTANTIA-NIGRA; BRAIN; TRANSPORTER; PET; DISORDERS; PATHOLOGY; NETWORKS;
D O I
10.1016/j.nicl.2017.03.011
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
A progressive loss of dopamine neurons in the substantia nigra (SN) is considered the main feature of idiopathic Parkinson's disease (PD). Recent neuropathological evidence however suggests that the axons of the nigrostriatal dopaminergic system are the earliest target of a-synuclein accumulation in PD, thus the principal site for vulnerability. Whether this applies to in vivo PD, and also to the mesolimbic system has not been investigated yet. We used [C-11]FeCIT PET to measure presynaptic dopamine transporter (DAT) activity in both nigrostriatal and mesolimbic systems, in 36 early PD patients (mean disease duration in months +/- SD 21.8 +/- 10.7) and 14 healthy controls similar for age. We also performed anatomically-driven partial correlation analysis to evaluate possible changes in the connectivity within both the dopamine networks at an early clinical phase. In the nigrostriatal system, we found a severe DAT reduction in the afferents to the dorsal putamen (DPU) (eta(2) = 0.84), whereas the SN was the less affected region (eta(2) = 0.31). DAT activity in the ventral tegmental area (VTA) and the ventral striatum (VST) were also reduced in the patient group, but to a lesser degree (VST eta(2) = 0.71 and VTA eta(2) = 0.31). In the PD patients compared to the controls, there was a marked decrease in dopamine network connectivity between SN and DPU nodes, supporting the significant derangement in the nigrostriatal pathway. These results suggest that neurodegeneration in the dopamine pathways is initially more prominent in the afferent axons and more severe in the nigrostriatal system. Considering PD as a disconnection syndrome starting from the axons, it would justify neuroprotective interventions even if patients have already manifested clinical symptoms.
引用
收藏
页码:734 / 740
页数:7
相关论文
共 50 条
  • [11] Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease
    Ishibashi, K.
    Kanemaru, K.
    Saito, Y.
    Murayama, S.
    Oda, K.
    Ishiwata, K.
    Mizusawa, H.
    Ishii, K.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (01): : 46 - 51
  • [12] MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson's disease
    Wang, Jianli
    Yang, Qing X.
    Sun, Xiaoyu
    Vesek, Jeffrey
    Mosher, Zachary
    Vasavada, Megha
    Chu, Jonathan
    Kanekar, Sangam
    Shivkumar, Vikram
    Venkiteswaran, Kala
    Subramanian, Thyagarajan
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (06) : 590 - 596
  • [13] Dopamine transporter binding in the nigrostriatal and mesocortical systems during gait in Parkinson's disease
    Ouchi, Y
    Kanno, T
    Okada, H
    Yoshikawa, E
    Futatsubashi, M
    Nobezawa, S
    Torizuka, T
    Sakamoto, M
    POSITRON EMISSION TOMOGRAPHY IN THE MILLENNIUM, 2000, 1197 : 53 - 59
  • [14] Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
    Heng, Nicholas
    Malek, Naveed
    Lawton, Michael A.
    Nodehi, Anahita
    Pitz, Vanessa
    Grosset, Katherine A.
    Ben-Shlomo, Yoav
    Grosset, Donald G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (04): : 539 - 546
  • [15] Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease
    Drui, G.
    Carnicella, S.
    Carcenac, C.
    Favier, M.
    Bertrand, A.
    Boulet, S.
    Savasta, M.
    MOLECULAR PSYCHIATRY, 2014, 19 (03) : 358 - 367
  • [16] Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease
    Kas, Aurelie
    Bottlaender, Michel
    Gallezot, Jean Dominique
    Vidailhet, Marie
    Villafane, Gabriel
    Gregoire, Marie Claude
    Coulon, Christine
    Valette, Heric
    Dolle, Frederic
    Ribeiro, Maria-Joao
    Hantraye, Philippe
    Remy, Philippe
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 (09) : 1601 - 1608
  • [17] Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease
    Kim, Han-Kyeol
    Kim, Tae Won
    Baek, Min Seok
    Kim, Eung Yeop
    Sung, Young Hee
    Lee, Jae Hoon
    Ryu, Young Hoon
    Ahn, Sung Jun
    Yoo, Han Soo
    Lyoo, Chul Hyoung
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (06) : 1639 - 1647
  • [18] Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera, Andrea
    Munoz, Patricia
    Steinbusch, Harry W. M.
    Segura-Aguilar, Juan
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (04): : 702 - 711
  • [19] Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effect
    Ishibashi, Kenji
    Oda, Keiichi
    Ishiwata, Kiichi
    Ishii, Kenji
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 339 (1-2) : 207 - 209
  • [20] Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease
    Ziegler, Erik
    Rouillard, Maud
    Andre, Elodie
    Coolen, Tim
    Stender, Johan
    Balteau, Evelyne
    Phillips, Christophe
    Garraux, Gaetan
    NEUROIMAGE, 2014, 99 : 498 - 508